The FY24 TERP TRA is intended to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies, and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science or vice versa in developing and implementing the research plan.
Impact: Applications should explain how the proposed research will have a significant impact on military-related toxic exposure research and/or patient care with the intent to transition outcome(s)/product(s) (intellectual knowledge and/or tangible materiel) into clinical practice for Service Members, their Families, Veterans, and/or the American public who have been or could potentially be impacted by toxic exposures. Applications should demonstrate both the short- and long-term impacts and how the successful completion of the proposed research will impact a critical problem or question in the field of research and/or patient care in at least one of the FY24 TERP Program Goals and at least one of the FY24 TERP Topic Areas.
Translational Potential: Projects should integrate basic science and clinical observations to accelerate the movement of promising ideas in military-related toxic exposure research toward clinical applications including health care products, interventions, technologies or clinical practice guidelines that are relevant to Service Members, their Families, Veterans, and/or the American public. The application should also demonstrate the reciprocal transfer of information between basic and clinical scientists.
Deadlines:
• Required Pre-Application Submission Deadline: Aug. 13, 2024
• Application Submission Deadline: Nov. 7, 2024
Topic Areas: The FY24 TERP Topic Areas are not listed in order of importance.
1. Neurotoxin Exposure
2. Gulf War Illness (GWI) and Its Treatment
3. Airborne Hazards and Burn Pits
4. Other Military Service-Related Toxic Exposures in General, Including Prophylactic Medications, Pesticides, Organophosphates, Toxic Industrial Chemicals, Materials, Metals and Minerals
Extramural and intramural DOD investigators at or above the level of Assistant Professor (or equivalent) may be named by the organization as the Principal Investigator (PI) or Partnering PI(s) on the application.
Applicants are discouraged from being named as a Partnering PI on multiple applications unless they are clearly addressing distinct research questions.
The anticipated direct costs budgeted for the entire period of performance for an FY24 TERP Translational Research Award should not exceed $800,000 for the Single PI Option and $1,600,000 (combined direct costs) for the Partnering PI Option. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.